InsidersTradesSigma
Follow the Laurus Labs Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Laurus Labs Limited has logged 94 insider filings. Market capitalisation: €962.5bn. The latest transaction was disclosed on 6 December 2024 (Pledge). Among the most active insiders: NURUBHASHA BABCHAND. The full history is openly available.
94
Insider Decl.
n/a
Thresholds
€230,889
9 ops.
Buy Volume
€11m
63 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Laurus Labs Limited Hold (neutral), based on 14 analysts. Average price target: ₹1,486.29.
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,316 of 29,064 companies
50.5
score / 100
Value27
Quality74
FCF yld0.6%
Earn yld0.9%
EV/EBITDA54.2x
ROE18%
Gross mgn59%
Net mgn13%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 December 2024
Declarations94 total
200,000 shares@ ₹576.4053.2% of flowEquity SharesSEBI:f056e113b6d76c2ca2150ffbc16b0d83f54e802b
10,000 shares@ ₹376.00100.0% of flowEquity SharesSEBI:65a5ebe59fea5b64a320934230be0c60f5938025
3,992 shares@ ₹578.699951.9% of flowEquity SharesSEBI:533ed4ab7f20b74154ba14b1ace39f1f40980e44
2,906 shares@ ₹578.699937.9% of flowEquity SharesSEBI:f42d38f3df2b5437d430c3531e677c3a8b4b41c6
788 shares@ ₹578.700510.2% of flowEquity SharesSEBI:3366fdec688fd4954445e2ed651c1ee188c066c3
2,275 shares@ ₹525.9451100.0% of flowEquity SharesSEBI:9918aa918bf48f376276e65749d72798b1cc2fd3
10,000 shares@ ₹539.6671100.0% of flowEquity SharesSEBI:38648633ccebbcc5b348287b244fdaf2237aa5f6
10,245 shares@ ₹505.00100.0% of flowEquity SharesSEBI:3c64216c2911c4481747e64cfffb129684c055bf
12,000 shares@ ₹657.9167100.0% of flowEquity SharesSEBI:89cce66f57a00d5b944c713995d2af8d7b6e43a9
1,000 shares@ ₹650.007.8% of flowEquity SharesSEBI:70dd415dbf1f2fff1e417e60f5b64c1724e22ace
4,000 shares@ ₹650.9031.8% of flowEquity SharesSEBI:38a73e3679e9a0368c34fa465ac3b651400cd155
5,500 shares@ ₹657.000.0000% mcap100.0% of flowEquity SharesSEBI:3b480afbc23a058629b405c641fa3064b07d5c5c
3,000 shares@ ₹669.76430.0000% mcap100.0% of flowEquity SharesSEBI:69648c1b026d439e29642d979c59be7d7a2381e4
18,120 shares@ ₹703.27230.0000% mcap4.9% of flowEquity SharesSEBI:47edc5b96d5919ef4a2dcb5a7d387403d19e4e4c
20,000 shares@ ₹700.000.0000% mcap5.3% of flowEquity SharesSEBI:b764e1f7fab1b1c9f44ecd5b7252fd53243b16b9
67,657 shares@ ₹702.89240.0002% mcap18.2% of flowEquity SharesSEBI:8679313bcf167fe661ae23babba4951a458450ed
1,445 shares@ ₹700.99930.0000% mcap50.1% of flowEquity SharesSEBI:ff4d7d5e25c0c2d0470fdb1a36453dbb2b20936d
2,910 shares@ ₹688.65020.0000% mcap36.5% of flowEquity SharesSEBI:d7094110df1c126fb2f2988a96abed8cbf40527c
5,060 shares@ ₹688.650.0000% mcap63.5% of flowEquity SharesSEBI:d841479378fac38ef620176828126f861f5e726f
20,000 shares@ ₹686.000.0000% mcap50.0% of flowEquity SharesSEBI:db9fb14bf57d4a899c78847d77441a2534d75dca
6,500 shares@ ₹688.75150.0000% mcap89.0% of flowEquity SharesSEBI:bca8cc04a27c9c9810a2152f45418010ba142aa3
15,000 shares@ ₹687.33330.0000% mcap100.0% of flowEquity SharesSEBI:c1c3cddf953e72821edf1b79140eee6568300dff
100,000 shares@ ₹683.000.0002% mcap68.8% of flowEquity SharesSEBI:cca0346f49eb11a88e6d509fba87315a476c63c6
1,500 shares@ ₹466.170.0000% mcap11.0% of flowEquity SharesSEBI:3416b6b38ae404ebeaeeebb5147776a5a23dd514
25 of 94 declarations
关于 Laurus Labs Limited
Laurus Labs Limited 是一家印度制药公司，从事仿制药产品的研究、开发和制造。它主要专注于抗逆转录病毒药物和医疗保健产品。